Businesses of all types can learn a lot from what pharma companies do when their blockbuster drugs come off patent. Some fall off the revenue cliff, and some — like Viagra — do a remarkable job of holding share. In this episode, the team highlights what any business that faces low-priced competition can learn from Viagra’s continued success.
About the Author
Mary Abbazia
Mary Abbazia is a strategic marketing consultant. Along with her partners Tom Spitale and Sean Welham, they help an impressive list of b2b clients differentiate their products and services through their work at Impact Planning Group. Tom and Mary are co-authors of the firm's book The Accidental Marketer, published by Wiley.
More About Mary
About the Author
Tom Spitale
Tom Spitale is a strategic marketing consultant. Along with his partners Mary Abbazia and Sean Welham, they help an impressive list of b2b clients differentiate their products and services through their work at Impact Planning Group. Tom and Mary are co-authors of the firm's book The Accidental Marketer, published by Wiley.
More About Tom
About the Author
Sean Welham
Sean Welham has worked extensively around the world in business-to-business strategic marketing. His work as a speaker, trainer, and consultant is predominantly in the technical and scientific arena with clients ranging from jet engines to oil and gas production and from agricultural chemicals to pharmaceuticals.
More About Sean